Using population crossover trials to improve the decision process regarding treatment individualization in \(N\)-of-1 trials
From MaRDI portal
Publication:6628468
DOI10.1002/sim.9030zbMATH Open1546.62189MaRDI QIDQ6628468
Publication date: 29 October 2024
Published in: Statistics in Medicine (Search for Journal in Brave)
empirical Bayesvariance componentscrossover trialsrandom effects linear models\(N\)-of-1 trialsindividual treatment benefits
Cites Work
- Unnamed Item
- Unnamed Item
- Personalized treatment for longitudinal data using unspecified random-effects model
- Optimal two treatment repeated measurement designs for three periods
- Prediction of Random Effects in Linear and Generalized Linear Models under Model Misspecification
- Small Sample Inference for Fixed Effects from Restricted Maximum Likelihood
- Longitudinal and Panel Data
- Construction of the Design Matrix for Generalized Linear Mixed-Effects Models in the Context of Clinical Trials of Treatment Sequences
- Analysis of crossover designs with nonignorable dropout
This page was built for publication: Using population crossover trials to improve the decision process regarding treatment individualization in \(N\)-of-1 trials